These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 10467412
21. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Huang Y, Li X, Jiang J, Frank SJ. Oncogene; 2006 Dec 07; 25(58):7565-76. PubMed ID: 16785991 [Abstract] [Full Text] [Related]
22. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells. Huang M, Page C, Reynolds RK, Lin J. Gynecol Oncol; 2000 Oct 07; 79(1):67-73. PubMed ID: 11006034 [Abstract] [Full Text] [Related]
23. As2O3-induced c-Src/EGFR/ERK signaling is via Sp1 binding sites to stimulate p21WAF1/CIP1 expression in human epidermoid carcinoma A431 cells. Liu ZM, Huang HS. Cell Signal; 2006 Feb 07; 18(2):244-55. PubMed ID: 15961274 [Abstract] [Full Text] [Related]
24. Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance. Vega MI, Huerta-Yepaz S, Garban H, Jazirehi A, Emmanouilides C, Bonavida B. Oncogene; 2004 Apr 29; 23(20):3530-40. PubMed ID: 15077178 [Abstract] [Full Text] [Related]
25. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Real PJ, Sierra A, De Juan A, Segovia JC, Lopez-Vega JM, Fernandez-Luna JL. Oncogene; 2002 Oct 31; 21(50):7611-8. PubMed ID: 12400004 [Abstract] [Full Text] [Related]
26. EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytes. Guren TK, Ødegård J, Abrahamsen H, Thoresen GH, Susa M, Andersson Y, Østby E, Christoffersen T. J Cell Physiol; 2003 Jul 31; 196(1):113-23. PubMed ID: 12767047 [Abstract] [Full Text] [Related]
27. Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression. Diaz N, Minton S, Cox C, Bowman T, Gritsko T, Garcia R, Eweis I, Wloch M, Livingston S, Seijo E, Cantor A, Lee JH, Beam CA, Sullivan D, Jove R, Muro-Cacho CA. Clin Cancer Res; 2006 Jan 01; 12(1):20-8. PubMed ID: 16397019 [Abstract] [Full Text] [Related]
28. EGF receptor signaling inhibits keratinocyte apoptosis: evidence for mediation by Bcl-XL. Stoll SW, Benedict M, Mitra R, Hiniker A, Elder JT, Nuñez G. Oncogene; 1998 Mar 01; 16(11):1493-9. PubMed ID: 9580112 [Abstract] [Full Text] [Related]
30. Modulation of prostaglandin G/H synthase expression in mesangial cells transfected by pp60c-src proto-oncogene. Reiser CO, Marx M, Hoppe J, Goppelt-Struebe M. Exp Cell Res; 1996 Feb 01; 222(2):304-11. PubMed ID: 8598218 [Abstract] [Full Text] [Related]
31. Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. Mao W, Irby R, Coppola D, Fu L, Wloch M, Turner J, Yu H, Garcia R, Jove R, Yeatman TJ. Oncogene; 1997 Dec 18; 15(25):3083-90. PubMed ID: 9444956 [Abstract] [Full Text] [Related]
32. Sorafenib induces apoptosis in HL60 cells by inhibiting Src kinase-mediated STAT3 phosphorylation. Zhao W, Zhang T, Qu B, Wu X, Zhu X, Meng F, Gu Y, Shu Y, Shen Y, Sun Y, Xu Q. Anticancer Drugs; 2011 Jan 18; 22(1):79-88. PubMed ID: 20881478 [Abstract] [Full Text] [Related]
33. Downregulation of the early genomic growth factor response in neu oncogene-transformed cells. Sistonen L, Koskinen PJ, Lehväslaiho H, Lehtola L, Bravo R, Alitalo K. Oncogene; 1990 Jun 18; 5(6):815-21. PubMed ID: 1972791 [Abstract] [Full Text] [Related]
34. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line. Lansing TJ, Turk BF, Kanner SB, Gilmer TM. Cancer Res; 1997 May 15; 57(10):1962-9. PubMed ID: 9157992 [Abstract] [Full Text] [Related]
35. Cells in vivo and in vitro from osteopetrotic mice homozygous for c-src disruption show suppression of synthesis of osteopontin, a multifunctional extracellular matrix protein. Chackalaparampil I, Peri A, Nemir M, Mckee MD, Lin PH, Mukherjee BB, Mukherjee AB. Oncogene; 1996 Apr 04; 12(7):1457-67. PubMed ID: 8622862 [Abstract] [Full Text] [Related]
36. Regulation of pp60c-src expression in rat and mouse fibroblasts by an inducible antisense gene: effects on serum regulation of growth and polyoma virus middle T function. Talmage DA, Riney C, Benjamin TL. Cell Growth Differ; 1991 Jan 04; 2(1):51-8. PubMed ID: 1706618 [Abstract] [Full Text] [Related]
37. An EGF receptor/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity. Goi T, Shipitsin M, Lu Z, Foster DA, Klinz SG, Feig LA. EMBO J; 2000 Feb 15; 19(4):623-30. PubMed ID: 10675331 [Abstract] [Full Text] [Related]
38. Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase. Zheng XM, Wang Y, Pallen CJ. Nature; 1992 Sep 24; 359(6393):336-9. PubMed ID: 1383828 [Abstract] [Full Text] [Related]
39. Neu-mediated phosphorylation of protein tyrosine phosphatase epsilon is critical for activation of Src in mammary tumor cells. Berman-Golan D, Elson A. Oncogene; 2007 Oct 25; 26(49):7028-37. PubMed ID: 17486066 [Abstract] [Full Text] [Related]
40. Enhanced EGF mitogenic response is associated with enhanced tyrosine phosphorylation of specific cellular proteins in fibroblasts overexpressing c-src. Wilson LK, Parsons SJ. Oncogene; 1990 Oct 25; 5(10):1471-80. PubMed ID: 1701230 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]